Study to Evaluate Central venous Catheter-related Infections in Hematology and Oncology

Conditions

T82.7

Kriege O, Böll B, Brüder N, Giesen N, Lanznaster J, Mertins S, Minti A, Naendrup JH, Schmidt-Hieber M, Seggewiss-Bernhardt R, Weber P, Wille K, Panse J, Hentrich M, Schalk E, SECRECY Investigators.

2026-07-10

10.1007/s15010-026-02888-7

Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study

Jens Panse, D Tölle, Eva Fiegle, Jan‐Hendrik Naendrup, Martin Schmidt‐Hieber et al. (9 authors)

Annals of Hematology2022-08-177 citations

10.1007/s00277-022-04958-w

Interventions

Group 1: Evaluation of epidemiological data and risc factors on infections due to central venous catheters (CVC)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: In-patient therapy in the Department of Hematology and Oncology; indication for CVC insertion for therapeutic itention; informed consent for CVC insertion for therapeutic intenion

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Prevalence and incidence of CVC infections (CRBSI, catheter-related bloodstream infections) in hematology and oncology (using the AGIHO/DGHO 2014 criteria); using the Infection Probability Score (IPS) and determine a cut-off value for CVC infection	—

Secondary

Measure	Time frame
Risk factors; germ spectrum; complications	—

Countries

Germany

Contacts

Public ContactChristine Friedrichs

Universitätsklinikum Magdeburg A.ö.R., Klinik für Hämatologie und Onkologie, Studiensekretariat

christine.friedrichs@med.ovgu.de+49 (0) 391 67 13134

Outcome results

None listed